Carl D. Quinion

Orthopedics
460 W 10th Ave
Columbus, OH 43210

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Correction: Tinoco et al. Clear Cell and Histiocytic/Dendritic Cell Sarcomas: Clinical Outcomes, Molecular Features, and Diagnostic Pitfalls. Cancers 2026, 18, 641.

Correction: Tinoco et al. Clear Cell and Histiocytic/Dendritic Cell Sarcomas: Clinical Outcomes, Molecular Features, and Diagnostic Pitfalls. Cancers 2026, 18, 641.

Journal: Cancers
Published: July 02, 2026

Prognostic value of tip-to-apex distance in prophylactic fixation for pathological peritrochanteric femur fractures.

Prognostic value of tip-to-apex distance in prophylactic fixation for pathological peritrochanteric femur fractures.

Journal: Journal of orthopaedics
Published: February 12, 2026

Clear Cell and Histiocytic/Dendritic Cell Sarcomas: Clinical Outcomes, Molecular Features, and Diagnostic Pitfalls.

Clear Cell and Histiocytic/Dendritic Cell Sarcomas: Clinical Outcomes, Molecular Features, and Diagnostic Pitfalls.

Journal: Cancers
Published: December 16, 2025

Response to: Do Obese Children Have Poor Patient-reported Outcomes After Closed Reduction and Percutaneous Pin Fixation of Supracondylar Humerus Fractures?

Response to: Do Obese Children Have Poor Patient-reported Outcomes After Closed Reduction and Percutaneous Pin Fixation of Supracondylar Humerus Fractures?

Journal: Journal of pediatric orthopedics
Published: April 26, 2021

Do Obese Children Have Poor Patient-reported Outcomes After Closed Reduction and Percutaneous Pin Fixation of Supracondylar Humerus Fractures?

Do Obese Children Have Poor Patient-reported Outcomes After Closed Reduction and Percutaneous Pin Fixation of Supracondylar Humerus Fractures?

Journal: Journal of pediatric orthopedics
Published: January 22, 2021

De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort.

De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort.

Journal: American journal of hematology
Published: October 16, 2015

Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation.

Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation.

Journal: Blood
Published: December 31, 2014

Human leukocyte antigen type and posttransplant lymphoproliferative disorder.

Human leukocyte antigen type and posttransplant lymphoproliferative disorder.

Journal: Transplantation
Published: November 27, 2014

Bruton's tyrosine kinase inhibitors in B-cell non-Hodgkin's lymphomas.

Bruton's tyrosine kinase inhibitors in B-cell non-Hodgkin's lymphomas.

Journal: Clinical pharmacology and therapeutics
Published: November 03, 2014

FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.

FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.

Journal: Blood
Published: November 02, 2011
Showing 1-10 of 10

Last Updated: 09/26/2026